United States · FDA National Drug Code directory
Novolin N
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0169-1834_652d3fd6-809f-476e-9159-a1beffb9ea01
- Product NDC
- 0169-1834
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- Human Insulin
- Labeler
- Novo Nordisk
- Marketing category
- BLA
- Marketing start / end (source format)
- 19910701
- Source listing expiry
- 20261231
Source-listed ingredients
- INSULIN HUMAN — 100 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (0169-1834-02) / 10 mL in 1 VIAL · 0169-1834-02
- 1 VIAL in 1 CARTON (0169-1834-11) / 10 mL in 1 VIAL · 0169-1834-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →